Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

NCT00063570 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast Neoplasms

Interventions

DRUG: Pemetrexed
DRUG: Gemcitabine
DRUG: Gemcitabine
DRUG: Pemetrexed

Sponsor

Eli Lilly and Company